Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy

Narendran, G. and Menon, P. A. and Venkatesan, P. and Vijay, K. and Padmapriyadarsini, C. and Ramesh Kumar, S. and Bhavani, K. P. and Sekar, L. and Gomathi, S. N. and Chandrasekhar, C. and Kumar, S. and Sridhar, R. and Swaminathan, S. (2014) Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy. Clinical Infectious Diseases, 59 (12). pp. 1798-1804. ISSN 1058-4838

Archive 201473.pdf - Published Version Download (1MB)

Affiliation:	ICMR-National Institute for Research in Tuberculosis
Item Type:	Article
Uncontrolled Keywords:	HIV; tuberculosis; drug-resistant tuberculosis; intermittent therapy; acquired rifampicin
Subjects:	Tuberculosis > Clinical Research
Divisions:	Clinical Research
Depositing User:	Dr. Rathinasabapati R
Date Deposited:	27 Sep 2022 11:29
Last Modified:	27 Sep 2022 11:29
URI:	http://eprints.nirt.res.in/id/eprint/1342

Actions (login required)

View Item